Allscripts and NantHealth are investing hundreds of millions of dollars in each other, deepening their commitment an existing partnership to develop a platform to bring personalized medicine to the point of care, particularly for cancer treatment.

The financial investments build on a partnership first reported in March, as the companies pursue a strategy to develop an integrated, evidence-based, personalized approach to treating patients, initially focusing on cancer care.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access